Common sense

Queclink Expands Its OBD Line with the GV500CNA, Designed for North American Markets

SHANGHAI,Sept. 11,2024-- Queclink,the world-leading IoT device and solution provider,announced the launch of its latest innovation,the GV500CNA. Building on the success of the GV500CG for the Latam ma

09-12 Queclink Wireless Solutions Co., Ltd.

Automation Anywhere Surpasses Second Quarter Goals with Accelerating Momentum After Successful Autonomous AI Agent Launch and Early Customer Wins

Fourth consecutive quarter of non-GAAP operating income,with more than 70 percent of new andupsell bookings driven by AI-powered automation solutions

09-12 Automation Anywhere, Inc.

Collinson International's 2024 Travel Benefits and Customer Engagement Report reveals Asia Pacific consumers spend as high as USD10,000 per annum on travel

Travel is one of the highest credit card spend categories for Asia Pacific survey respondents,accounting for almost a third (27%) of annual expenditure.

09-12 Collinson International

NTT TechnoCross Recognized with Frost & Sullivan's 2024 Company of the Year Award for Leading Innovation in Japanese Privileged Access Management Solutions

NTT TechnoCross excels in developing innovative privileged access management (PAM) solutions tailored for the Japanese market,combining ease of use with robust security features.

09-12 Frost & Sullivan

COSRX Debuts Viral The 6 Peptide Skin Booster Serum at ULTA Stores Across the US with Experiential Pop Ups in California and New York

NEW YORK,Sept. 12,2024-- COSRX celebrates the in-store debut of the consistently sold-out,viral The 6 PeptideSkinBooster Serum by hosting experiential consumer one-day pop up events across six ULTA Be

09-12 COSRX

Finance Meets Technology: Unlocking Future Investment at VIFS 2024

VANCOUVER,BC,Sept. 10,2024-- In the ever-evolving global economy,challenges and opportunities coexist,leaving investors to ask: how can one stay ahead in such a dynamic market? The 2024 Vancouver Inte

09-11 FX168 Finance Group

Updated Data from Phase II Clinical Trial of Iruplinalkib Tablets (Qixinke®) Presented at World Conference on Lung Cancer 2024

JINAN,China,Sept. 10,2024-- During the World Conference on Lung Cancer (WCLC) held from September 7-10,2024,in San Diego,California,updated findings from the Phase II clinical trial (INTELLECT study)

09-11 Qilu Pharmaceutical Co., Ltd.

Relativity Deepens its Chicagoland Roots with CPS Academic Investment and New Headquarters

Relativity aims to cultivate Chicago\'s future tech talent through enhanced CPS partnership CHICAGO,Sept. 10,2024-- Relativity,a global legal technology company,today announced that it has strengthene

09-11 Relativity

Xiao-I Corporation Regains Compliance with Nasdaq Listing Rules

SHANGHAI,Sept. 10,2024-- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"),a leading artificial intelligence company,today announced that on September 9,2024 it receive

09-11 Xiao-I Corporation

Retail golden quarter: how AI can boost sales success for retailers

New DeepL white paper underscores how Language AI will enable retailers to reduce costs and grow revenue through better internal and external communication

09-11 DeepL US Inc.